OCRA News
Update on $15 Million Increase Request for OCRP Funding
(April 1, 2019) 156 House Members have joined Reps. DeLauro and Duffy in a call for increased ovarian cancer research funding. Reps…
Sign up for OCRA’s National Conference at Early Bird Registration Fee
Empower yourself with the latest research updates at OCRA’s National Conference. Register today. It can be overwhelming trying to keep up with what’s new in the ovarian cancer field, and how new discoveries may affect you…
Shop Designer Brands to End Ovarian Cancer
OCRA is now on Shopify and Poshmark Wardrobe need a refresh? Now you can shop high-end, limited quantity designer goods online at deep discounts, all while supporting the fight against ovarian cancer…
National Comprehensive Cancer Network Updates Guidelines
(March 26, 2019) The NCCN, or the National Comprehensive Cancer Network, recently updated its clinical guidelines for the treatment of ovarian cancers…
OCRA Funded Study Aims to Increase Efficacy of PARP Inhibitors
(March 20, 2019) The Ovarian Cancer Dream Team, funded in part by OCRA, recently completed a Phase 1b Trial, which combined a PARP inhibitor with an HRR (homologous recombination repair) pathway inhibitor, such as PI3K, in order to increase the…
OCRA Spring Advocacy Day 2019 Actions
(March 20, 2019) Earlier this month, OCRA united advocates from across the country for Spring Advocacy Day on Capitol Hill…
Action Alert: Tell Congress to Increase OCRP Funding
(March 19, 2019) Congress is considering a $15 million increase for OCRP funding. Urge YOUR Representative to sign the letter to help push this funding through…
Lymphadenectomy in Ovarian Cancer Patients Can Be Unnecessary
(March 18, 2019) Before the most recent study on the usage of lymphadenectomy, published earlier this month in the New England Journal of Medicine, it was thought that surgically removing clinically negative lymph nodes had a positive effect on the…
OCRA-Funded Research Indicates that Stem-Like Cells May Be Key to Preventing Recurrence
(March 15, 2019) Cell Reports recently published a study about a drug that, given in combination with chemotherapy, could greatly increase survival rates of ovarian cancer patients…
Statement from Audra Moran, President and CEO of Ovarian Cancer Research Alliance on the President’s FY2020 Budget
(March 12, 2019) “The President’s proposed FY2020 budget released by the White House on Monday seeks to cut medical research funding at the National Cancer Institute (NCI) by 15 percent – almost $900 million dollars compared to FY2019…
Remembering Lori Newcomb
(March 1, 2019) OCRA mourns the loss of our beloved board member and friend, Lori Newcomb…
Toni Harris, an Ovarian Cancer Survivor Making Football History
(February 28, 2019) Toni Harris, 22, is shaking up the world of college football, and making history as the first female to earn a scholarship to play at a 4-year university…